Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer.
Duffour J, Gourgou S, Desseigne F, Debrigode C, Mineur L, Pinguet F, Poujol S, Chalbos P, Bressole F, Ychou M. Duffour J, et al. Among authors: debrigode c. Cancer Chemother Pharmacol. 2007 Aug;60(3):383-9. doi: 10.1007/s00280-006-0372-9. Epub 2006 Nov 24. Cancer Chemother Pharmacol. 2007. PMID: 17124595 Clinical Trial.
Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure.
de Meric de Bellefon M, Lemanski C, Castan F, Samalin E, Mazard T, Lenglet A, Demontoy S, Riou O, Llacer-Moscardo C, Fenoglietto P, Aillères N, Thezenas S, Debrigode C, Vieillot S, Gourgou S, Azria D. de Meric de Bellefon M, et al. Among authors: debrigode c. Radiother Oncol. 2020 Mar;144:141-147. doi: 10.1016/j.radonc.2019.11.016. Epub 2019 Dec 3. Radiother Oncol. 2020. PMID: 31809980
Intra-operative radiotherapy in soft tissue sarcomas.
Dubois JB, Debrigode C, Hay M, Gely S, Rouanet P, Saint-Aubert B, Pujol H. Dubois JB, et al. Among authors: debrigode c. Radiother Oncol. 1995 Feb;34(2):160-3. doi: 10.1016/0167-8140(95)01515-i. Radiother Oncol. 1995. PMID: 7597215
Locoregional relapses in the ACCORD 12/0405-PRODIGE 02 study: Dosimetric study and risk factors.
Meillan N, Orthuon A, Chauchat P, Atlani D, Bouche O, Chaulin B, David C, Deberne M, Debrigode C, Kao W, Keller A, Laharie H, Lamezec B, Lemanski C, Magné N, Mahé MA, Mere P, Moureau-Zabotto L, Peiffert D, Pointreau Y, Quéro L, Racadot S, Roca S, Sargos P, Servagi S, Tang E, Vendrely V, Doyen J, Huguet F. Meillan N, et al. Among authors: debrigode c. Radiother Oncol. 2021 Aug;161:198-204. doi: 10.1016/j.radonc.2021.06.006. Epub 2021 Jun 16. Radiother Oncol. 2021. PMID: 34144078
Assessment of combined use of ArcCheck® detector and portal dosimetry for delivery quality assurance of head and neck and prostate volumetric-modulated arc therapy.
Moliner G, Sorro L, Verstraet R, Daviau PA, Casas M, Piron B, Dubois K, Debrigode C, Barrau C, Bons F, Greffier J. Moliner G, et al. Among authors: debrigode c. J Appl Clin Med Phys. 2018 Nov;19(6):133-139. doi: 10.1002/acm2.12460. Epub 2018 Oct 19. J Appl Clin Med Phys. 2018. PMID: 30338922 Free PMC article.
[Medulloblastoma in children].
Hideghety K, Kerr C, Debrigode C, Dubois JB. Hideghety K, et al. Among authors: debrigode c. Bull Cancer Radiother. 1994;81(2):143-6. Bull Cancer Radiother. 1994. PMID: 7702894 French. No abstract available.
12 results